Compare AstraZeneca plc (AZN) vs Baker Hughes Co (BKR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AstraZeneca plc vs Baker Hughes Co — how do they compare? AstraZeneca plc trades at $158.56 (market cap $250.84B), while Baker Hughes Co trades at $64.83 (market cap $63.60B). The key difference: AstraZeneca plc is far larger — about 3.9× Baker Hughes Co's market cap, and AstraZeneca plc pays the higher dividend (1.97%). Which is the better fit depends on your goals.
| AZN | BKR | |
|---|---|---|
Market Cap | $250.84B | $63.60B |
Sector | Health | Energy |
52-Week High | $209.48 | $69.67 |
52-Week Low | $147.06 | $42.51 |
Enterprise Value | $278.12B | $64.13B |
Dividend Yield | 1.97% | 1.44% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →About Baker Hughes Co
Baker Hughes is a global leader in oilfield services and oilfield equipment, with particularly strong presences in the artificial lift, specialty chemicals, and completions markets. The other half of its business focuses on industrial power generation, process solutions, and industrial asset management, with high exposure to the liquid natural gas market specifically, as well as broader industrials end markets.
Read more on BKR →
